BackTritium DCFC Limited - Warrants (13/01/2027) Overview

Tritium DCFC Limited - Warrants (13/01/2027) Total Current Liabilities

Tritium DCFC Limited - Warrants (13/01/2027)'s total current liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$0.00
100.00% YoYΔ $-211.55M vs prior year quarter

Peer average

Loading

Tritium DCFC Limited - Warrants (13/01/2027) Total Current Liabilities History

Loading

Tritium DCFC Limited - Warrants (13/01/2027) vs. peers: Total Current Liabilities Comparison

Loading

Tritium DCFC Limited - Warrants (13/01/2027) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tritium DCFC Limited - Warrants (13/01/2027) (DCFCW) FAQ

As of the most recent data (September 2023), DCFCW shows a total current liabilities of $0. That compares with $210M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DCFCW's total current liabilities is now $0 (was $210M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Tritium DCFC Limited - Warrants (13/01/2027) is outperforming or lagging.

Tracking DCFCW's total current liabilities over time shows whether Tritium DCFC Limited - Warrants (13/01/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $210M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Tritium DCFC Limited - Warrants (13/01/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $0) with ownership activity and broader fundamentals.